We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Randomised controlled trial: sequential vs. standard triple therapy for Helicobacter pylori infection in Chinese children-a multicentre, open-labelled study.
- Authors
Huang, J.; Zhou, L.; Geng, L.; Yang, M.; Xu, X.‐W.; Ding, Z.‐L.; Mao, M.; Wang, Z.‐L.; Li, Z.‐L.; Li, D.‐Y.; Gong, S.‐T.
- Abstract
Background Studies have showed that 10-day sequential treatment regimen achieved higher Helicobacter pylori eradication rate than standard triple therapies. Aim To compare a 10-day sequential therapy and standard triple therapy in Chinese children with H. pylori infection. Methods A prospective, multicentre, open-label, randomised controlled trial was conducted in four tertiary medical centres in China. Children with H. pylori gastritis were randomly assigned to a 10-day sequential therapy consisting of omeprazole and amoxicillin for 5 days followed by omeprazole, clarithromycin and metronidazole for the remaining 5 days, or 7-day or 10-day standard triple therapy comprising of omeprazole, amoxicillin and clarithromycin. H. pylori eradication was assessed by H. pylori stool antigen test. Results A total of 360 patients were included. The eradication rate achieved with the 10-day sequential therapy was significantly higher than either the 7-day or 10-day standard triple treatment, either by the intention-to-treat analysis (81.4% vs. 61.9% or 67.7%, P < 0.05) or per-protocol analysis (89.7% vs. 70.8% or 77.8%, P < 0.05). Conclusions The 10-day sequential regimen was significantly more effective than standard 7-day or 10-day triple regimens in eradicating H. pylori infection in Chinese children.
- Subjects
RANDOMIZED controlled trials; TREATMENT of helicobacter pylori infections; PEDIATRIC therapy; OMEPRAZOLE; AMOXICILLIN; CLARITHROMYCIN; METRONIDAZOLE
- Publication
Alimentary Pharmacology & Therapeutics, 2013, Vol 38, Issue 10, p1230
- ISSN
0269-2813
- Publication type
Article
- DOI
10.1111/apt.12516